Home > Name List By v > Vapreotide

CAS No 103222-11-3 , Vapreotide

  • Name: Vapreotide
  • Synonyms: 3: PN: EP1118336 SEQID: 3 claimed protein; RC 160;1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv.; 16: PN: US20020042374 PAGE: 10 claimed protein; Vapreotide; 20: PN:US6268342 SEQID: 23 claimed protein;BMY 41606; Octastatin; RC 160 (protein);Vapreotide;
  • CAS Registry Number:
  • Density: 1.4 g/cm3
  • Refractive index: 1.699
  • Safety Statements: 22-24/25
  • Molecular Weight: 1131.37
  • InChI: InChI=1/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)
  • Molecular Formula: C57H70N12O9S2
  • Molecular Structure:CAS No:103222-11-3 Vapreotide

Related products

Search by region :

Select to

103222-11-3 Vapreotide

  • China Hwasun Biotechnology Co., Ltd. null
  • Fax: 86-21-64765024
  • Address: Rm.505, Bldg. 2,No. 245 Jiachuan RD. Xuhui Dist.,200237, Shanghai, China null,nullChina
Contact Supplier

103222-11-3 L-Tryptophanamide,D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-,cyclic (2®7)-disulfide

  • China Hybio Pharmaceutica Co.,Ltd [Manufacturers]
  • Tel: +86 755 26588093,
  • Fax: +86 755 26588022
  • Address: Hybio Medicine Park, No. 37, Keji C. Str 2nd Shenzhen Hi-tech Industrial Park 518057 P.R.China null,guangdongChina
Contact Supplier

Select to

References of Vapreotide
Title: Vapreotide
CAS Registry Number: 103222-11-3
CAS Name: D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2?7)-disulfide
Manufacturers' Codes: BMY-41606; RC-160
Trademarks: Octastatin (Debiopharm)
Molecular Formula: C57H70N12O9S2
Molecular Weight: 1131.37
Percent Composition: C 60.51%, H 6.24%, N 14.86%, O 12.73%, S 5.67%
Literature References: Octapeptide somatostatin analog. Prepn: A. V. Schally, R. Z. Cai, EP 203031 (1986 to Tulane); eidem, US 4650787 (1987). Inhibition of growth hormone, insulin and glucagon release: T. Karashima et al., Life Sci. 41, 1011 (1987); on pancreatic secretion: S. J. Konturek et al., Proc. Soc. Exp. Biol. Med. 187, 241 (1988). RIA determn in serum: M. Mason-Garcia et al., Proc. Natl. Acad. Sci. USA 85, 5688 (1988). Clinical pharmacology: M. A. Ritz et al., Br. J. Clin. Pharmacol. 47, 195 (1999). Clinical trial for variceal bleeding in cirrhosis: P. Calès et al., N. Engl. J. Med. 344, 23 (2001).
Therap-Cat: Hemostatic.
Keywords: Hemostatic; Somatostatin Analog.